Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Powerful HBO Documentary Moves New England Patriots Owner To Pledge Up To $500,000 To Progeria Research Foundation


News provided by

Progeria Research Foundation

Oct 10, 2013, 05:03 ET

Share this article

Share toX

Share this article

Share toX

In an effort to raise $1 million, Robert Kraft will match public contributions to Foundation from now until October 23, the 17th birthday of LIFE ACCORDING TO SAM subject, Sam Berns.

NEW YORK, Oct. 10, 2013 /PRNewswire-USNewswire/ -- Inspired at a screening of a new HBO Documentary film,  LIFE ACCORDING TO SAM, the Chairman and CEO of the NFL's New England Patriots on Tuesday pledged up to half a million dollars to the Progeria Research Foundation and a clinical trial that could lead to a treatment for the rare and fatal disease. Robert Kraft announced the pledge at the New York premiere of the film, which explores the life of Sam Berns, a 16-year-old boy with Progeria and son of The Progeria Research Foundation co-founders. To kick off a fundraising drive, Kraft said he will match every donation to the Progeria Research Foundation, up to $500,000, from now until Sam's 17th birthday on October 23. If the match is maximized, the Foundation will celebrate Sam's birthday knowing they raised $1 million to help fund the next clinical study in their pursuit to find a cure for Progeria. Donations can be made at the Progeria Research Foundation website.

Continue Reading
NFL New England Patriots owner Robert Kraft (left) with Sam Berns (center), at the New York premiere of the HBO Documentary LIFE ACCORDING TO SAM on October 8. Also pictured are (from left) Ricki Lander, and Sam's parents Scott Berns and Leslie Gordon. Kraft has pledged to match up to $500,000 in donations to the Progeria Research Foundation by October 23. LIFE ACCORDING TO SAM premieres on HBO on Monday, October 21 at 9 p.m. ET/PT. (PRNewsFoto/Progeria Research Foundation, Thos Robinson/Getty/HBO) (PRNewsFoto/PROGERIA RESEARCH FOUNDATION)
NFL New England Patriots owner Robert Kraft (left) with Sam Berns (center), at the New York premiere of the HBO Documentary LIFE ACCORDING TO SAM on October 8. Also pictured are (from left) Ricki Lander, and Sam's parents Scott Berns and Leslie Gordon. Kraft has pledged to match up to $500,000 in donations to the Progeria Research Foundation by October 23. LIFE ACCORDING TO SAM premieres on HBO on Monday, October 21 at 9 p.m. ET/PT. (PRNewsFoto/Progeria Research Foundation, Thos Robinson/Getty/HBO) (PRNewsFoto/PROGERIA RESEARCH FOUNDATION)

(Photo: http://photos.prnewswire.com/prnh/20131010/DC95856)

Directed by Academy Award-winning filmmakers Sean Fine and Andrea Nix Fine, LIFE ACCORDING TO SAM will debut on Monday, October 21 on HBO at 9 p.m. EDT/PDT. The film spotlights Sam's and his family's relentless pursuit of a treatment and cure for Progeria, while chronicling the teenager's typical schedule of high school, friends and family.

"I have fallen in love with Sam and I am sure that sentiment is shared by anyone who has ever spent time with him," said Kraft. "Life According to Sam is an amazing and powerful film that will introduce Sam, his family and his story to a national audience. Sam is a star and what his parents have achieved in their search to find a cure is incredibly inspirational. Together, they are championing a cause that has already positively impacted the lives of children around the world. This is a must-see film. It will make you laugh. It will make you cry. And, most importantly, I think it will motivate people to want to do more to help."

"As filmmakers, you hope that your work will move people to make a difference. We are honored to tell Sam and his family's story, and this pledge by Robert Kraft is beyond exciting," said Sean Fine and Andrea Nix Fine.

LIFE ACCORDING TO SAM is a highly personal and life-affirming journey championed by the presence of Sam himself. Funny, perceptive and fiercely intelligent, Sam is the catalyst of his parents' relentless drive to discover a medical breakthrough that may one day shed light on unlocking the aging process in us all.

In 1998 Dr. Leslie Gordon and Dr. Scott Berns learned that their two-year-old son, Sam, had Progeria. With little known about the disease at the time, they were told there was no treatment or cure. However, they refused to accept the diagnosis as a final verdict. Dr. Gordon and Dr. Berns founded The Progeria Research Foundation to drive Progeria research and to serve as a resource for children with Progeria and their families worldwide.

Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS), is a rare genetic disease characterized by an appearance of accelerated aging in children. Currently there are fewer than 250 children in the world living with this condition. All children with Progeria die of the same heart disease that affects millions of normal aging adults (atherosclerosis), but instead of occurring at 60 or 70 years of age, these children may suffer heart attacks and strokes as early as age five, with the average age of death at 13 years.

In LIFE ACCORDING TO SAM, viewers see 11 years of breakthrough research, driven by Sam's parents, which led to the first experimental drug trial for Sam and 28 other children from around the world.

Since its premiere in January 2013 at the prestigious Sundance Film Festival, LIFE ACCORDING TO SAM has been honored with a number of awards. The film was selected for a  "Best of the Fest" special screening at the AFI Docs Festival in Washington, DC, the Audience Award Winner at the Nantucket, Newburyport, Woods Hole and Martha's Vineyard film festivals, Best Storytelling award at Nantucket and Best Feature Documentary at the Rhode Island international film festival.

What people are saying about Life According to Sam:
"Powerful film on life, love, hope, family, medicine"
"When I grow up I want to be as wise as Sam and as positive as Leslie"
"…The sweetest, life-affirming film … stunning and thought-provoking"

About The Progeria Research Foundation (PRF)
The Progeria Research Foundation (PRF) was established in 1999 to find the cause, treatment and cure for Progeria – a rapid aging disease that causes children to die from heart disease or stroke at an average age of 13 years. Over the past 14 years, research conducted in partnership with PRF has identified the gene that causes Progeria and possible treatments.  PRF funded and coordinated the first-ever Progeria clinical trial to test the farnesyltransferase inhibitor (FTI) lonafarnib, which is featured in the film. PRF is currently funding a clinical trial in which children with Progeria receive FTI plus two additional medications, hoping the 3-drug combination will slow the progression of Progeria.  PRF continues to identify more children who can benefit from the programs and services that it provides while helping advance research towards treatment and cure.  To learn more about Progeria and what you can do to help, please visit www.progeriaresearch.org.

SOURCE Progeria Research Foundation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.